Fundraising Fox

Apex Therapeutics

Indianapolis, US · Delaware corporation

Biotech

Founders & leadership

DB
David BroeckerChief Executive Officer; Member of Board of Directors
MR
Mark R. Kelly, PhDChief Scientific Officer; Member of Board of Directors
RM
Richard Messman, MDChief Medical Officer
RM
Roger MillerChief Operating Officer

Board

HP
Homer PearceBoard director
MH
Martin Haslanger, PhDMember of Board of Directors; CEO Emeritus
JB
John BarnardMember of Board of Directors; Chairman

Reported raises · per SEC filings

Form D private placements

$5.2M disclosed across 5 rounds · 2015–2019

▶$150KraisedMar 2019 · 1 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Timothy TichenorExecutive Officer
  • John BarnardDirector
  • Mark R. Kelley, PhDDirector
  • Martin Haslanger, PhDDirector
  • Roger MillerExecutive Officer
  • David BroeckerDirector, Executive Officer
  • Richard MessmannExecutive Officer
  • Homer Pearce, PhDDirector
Offering amount
$2M
Amount sold
$150K
Proceeds to insiders
$100K
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$2.8MraisedJul 2018 · 7 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Timothy TichenorExecutive Officer
  • Mark R. Kelley, PhDDirector
  • Roger MillerExecutive Officer
  • Richard MessmannExecutive Officer
  • Steve CarchediExecutive Officer, Director
  • John BarnardDirector
  • Homer Pearce, PhDDirector
  • David BroeckerDirector
  • Martin Haslanger, PhDDirector
Amount sold
$2.8M
Proceeds to insiders
$50K
First sale
Jul 2017
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$1.3MraisedDec 2016 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Roger MillerExecutive Officer
  • Homer PearceDirector
  • Steve CarchediExecutive Officer, Director
  • Martin Haslanger, PhDDirector
  • Mark R. Kelly, PhDExecutive Officer, Director
  • John BarnardDirector
  • David BroeckerDirector
Offering amount
$1.5M
Amount sold
$1.3M
Minimum investment
$50K
Proceeds to insiders
$50K
First sale
Oct 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$750KraisedFeb 2016 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark Kelly, PhDExecutive Officer, Director
  • John BarnardDirector
  • David BroeckerExecutive Officer, Director
  • Homer PearceDirector
  • Roger MillerExecutive Officer
  • Martin Haslanger, PhDDirector
Offering amount
$750K
Amount sold
$750K
Minimum investment
$125K
Proceeds to insiders
$60K
First sale
Dec 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$275KraisedJun 2015 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David BroeckerExecutive Officer, Director
  • Mark R. Kelly, PhDExecutive Officer, Director
  • Homer PearceDirector
  • Martin Haslanger, PhDDirector
  • John BarnardDirector
  • Richard Messman, MDExecutive Officer
  • Roger MillerExecutive Officer
Offering amount
$650K
Amount sold
$275K
Minimum investment
$25K
Proceeds to insiders
$45K
First sale
Jun 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Apex Therapeutics raised?
Apex Therapeutics has disclosed $5.2M raised across 5 rounds.
Where is Apex Therapeutics headquartered?
Apex Therapeutics is headquartered in Indianapolis, US.